Skip to Content

0599 (Imatinib Mesylate 400 mg)

Pill with imprint 0599 is Brown, Capsule-shape and has been identified as Imatinib Mesylate 400 mg. It is supplied by Breckenridge Pharmaceutical, Inc..

Imatinib is used in the treatment of chronic myelogenous leukemia; acute lymphoblastic leukemia; chronic eosinophilic leukemia; dermatofibrosarcoma protuberans; gastrointestinal stromal tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 0599

Imatinib Mesylate

Imprint
0599
Strength
400 mg
Color
Brown
Shape
Capsule-shape
Availability
Prescription only
Drug Class
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Breckenridge Pharmaceutical, Inc.
Manufacturer
Stason Pharmaceuticals, Inc.
National Drug Code (NDC)
51991-0377

Get help with Imprint Code FAQs.

Related Images for "0599"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.